1.	Phase III Randomized, Double-Blind Study of Warfarin vs Placebo for Chemoprevention of Thrombosis in Central Venous Access Catheters in Cancer Patients (Summary Last Modified 12/1999) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: CCCWFU-97194, NCI-P95-0064
2.	Phase III MACC (MTX/ADR/CCNU/CTX) vs MACC/Warfarin vs MACC Alternating with MEPH (MITO/VP-16/CACP/HMM) for Extensive Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Completed Age: 21 to 69 Sponsor: NCI Protocol IDs: CLB-8084, CALGB-8084
3.	Phase III Randomized Study of Adjuvant Anticoagulation Therapy with Warfarin for Stage II/III Adenocarcinoma of the Colon Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-GI-82351
4.	Phase III Adjuvant Chemotherapy with Urokinase or Urokinase/Warfarin for Resectable Dukes B/C Adenocarcinoma of the Colon and Rectum Phase: Phase III Type: Treatment Status: Closed Age: under 70 Sponsor: Protocol IDs: EORTC-19793, UKM-HH-1
5.	Phase III Randomized Comparison of Warfarin vs No Warfarin in Combination with Intensive Chemotherapy Using ACE (ADR/CTX/VP-16) and PCE (CDDP/CTX/VP-16) plus Primary Thoracic and Prophylactic Whole-Brain Radiotherapy in Limited Small Cell Lung Cancer (Summary Last Modified 12/91) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-8534, CALGB-8534
6.	Phase I/II Pilot Study of Intensive Combination Chemotherapy with Sequential ACE (ADR/CTX/VP-16) and PCE (CACP/CTX/VP-16) plus Chest Irradiation and Warfarin in Patients with Limited Small Cell Carcinoma of the Lung Phase: Phase II, Phase I Type: Treatment Status: Closed Age: over 21 Sponsor: NCI Protocol IDs: CLB-8532, CALGB-8532
7.	Adjuvant Chemotherapy with DTIC or BCNU/ACT-D/VCR with or without Anticoagulation for Resectable Stage II-III Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D78-026-202, RPMI-PPC-580
8.	Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 00-113, MSKCC-00113, NCI-G01-1927, NCT00014352
9.	Phase II Pilot Study of Combined Warfarin/RA-233 in Patients with Advanced Cancer (Summary Last Modified 09/87) Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: DMS-8308, NCI-V87-0190
10.	Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000386239, P30CA016042, UCLA-0403067-01, NOVARTIS-CPTK7870113, NCT00091299
11.	Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CEPO906A2120, NCT00448396
12.	A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma Phase: Phase I Type: Treatment Status: Closed Age: 18 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: NP22676, NCT01001299
13.	BAY73-4506 Probe Substrate Study Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12434, NCT01287598
14.	A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PXD101-CLN-20, NCT01317927
15.	A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: 9763, H6Q-MC-JCAX, NCT01388335
16.	Randomized Study of Warfarin as Thrombosis Prophylaxis in Cancer Patients With Central Venous Catheters. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Supportive care Status: Closed Age: 16 and over Sponsor: Other Protocol IDs: CRC-WARP, EU-20049, NCT00024297
17.	Randomized, Placebo-Controlled Trial of Low-Dose Warfarin in the Prevention of Subclavian Vein Thrombosis in Adenocarcinoma Patients with Indwelling Subclavian Venous Catheters (Summary Last Modified 07/90) Phase: No phase specified Type: Supportive care Status: Closed Age: 16 and over Sponsor: Protocol IDs: FCCC-87885, NCI-V87-0299